Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies

Neurogastroenterology and Motility

Volumn 23, Issue 5, 2011, Pages 419-426

  Sweis, R ^a   Fox, M ^b   Anggiansah, A ^a   Wong, T ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Bravo; Heartburn; PH catheter; Regurgitation

Indexed keywords

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; DEVICE; DIAGNOSTIC VALUE; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; MALE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGED; CATHETERS; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79954421122     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01663.x     Document Type: Review

References (23)

1. Fass R, Hell R, Sampliner RE et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999; 44: 2263-9.
2. Gillies RS, Stratford JM, Booth MI, Dehn TC. Oesophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol 2007; 19: 57-63.
3. Sweis R, Fox M, Anggiansah R et al. Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther 2009; 29: 669-76.
4. Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 2007; 102: 2642-7.
5. Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3: 329-34.
6. Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-9.
7. National Institute for Health and Clinical Excellence (NICE). Catheterless Oesophageal pH Monitoring, Interventional Procedure Guidance 187. London, UK: NICE, 2006.
8. Bodger K, Trudgill N. Guidelines for Oesophageal Manometry and pH Monitoring. London (UK): British Society of Gastroenterology (BSG), 2006.
9. Pandolfino JE, Zhang Q, Schreiner MA, Ghosh S, Roth MP, Kahrilas PJ. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different? Gut 2005; 54: 1687-92.
10. Johnsson F, Joelsson B, Isberg PE. Ambulatory 24hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 1987; 28: 1145-50.
11. Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-56.
12. Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-5.
13. Lee JD, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. The effects of age on the gastro-esophageal junction, esophageal motility and reflux disease. Clin Gastroenterol Hepatol 2007; 5: 1392-8.
14. Labenz J, Nocon M, Lind T et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol 2006; 101: 2457-62.
15. Mainie I, Tutuian R, Castell DO. Comparison between the combined analysis and the DeMeester Score to predict response to PPI therapy. J Clin Gastroenterol 2006; 40: 602-5.
16. Wong WM, Bautista J, Dekel R et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring - a randomized trial. Aliment Pharmacol Ther 2005; 21: 155-63.
17. Bredenoord AJ, Weusten BL, Smout AJ. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 2005; 54: 1810-7.
18. Fox M, Schwizer W. Making sense of oesophageal contents. Gut 2008; 57: 435-8.
19. Campos GM, Peters JH, DeMeester TR et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292-300.
20. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006; 93: 1483-7.
21. Broeders JA, Draaisma WA, Bredenoord AJ et al. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. Br J Surg 2009; 96: 1023-30.
22. Connor J, Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol 2006; 101: 460-3.
23. Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-402.